Low-Dose Naltrexone Fails to Improve Fibromyalgia Outcomes in Clinical Trial A recent 12-month, randomized, double-blind, placebo-controlled trial has found that low-dose naltrexone (LDN) does not outperform a placebo in reducing …
Tag:
impairment
-
-
Bitcoin Price Vulnerability: Leverage and Macroeconomic Concerns Weigh on Crypto Market Table of Contents Bitcoin Price Vulnerability: Leverage and Macroeconomic Concerns Weigh on Crypto Market The Risk of Leverage in …
-
By leveraging a person-centered computational approach too phenotypic data from more than 5000 children with autism spectrum disorder (ASD), researchers have identified four biologically and clinically distinct subtypes of autism …
-
Decoding Biological Age: A New MRI-Based Tool for Predicting Cognitive Decline and Overall Health A groundbreaking advancement in age assessment has emerged, offering a precise method to determine an individual’s …
-
Gabapentin Use Associated with Increased Cognitive Decline Risk, But Causation Remains Unclear Recent research suggests a potential link between teh use of gabapentin, a commonly prescribed medication, and an elevated …
-
Breaking News: APA Updates Guidelines for Borderline Personality Disorder After a two-decade gap, the American Psychiatric Association (APA) has released updated clinical practice guidelines for borderline personality disorder (BPD), marking …